Then gene set enrichment analysis (GSEA) and in vivo and in vitro experiments showed that RORA might inhibit the migration, invasion, and EMT of GBM by regulating the TGF-β1/Smad signaling pathway. The gene discussed is TGFB1; the disease is glioblastoma.